NCT07436156RecruitingPhase 4
SUMMIT RISE Study of Acute Ischemic Stroke Patients
SUMMIT RISE Study of Acute Ischemic Stroke Patients Evaluating the Route 92 Medical Reperfusion Systems.
Source: ClinicalTrials.gov · Last updated 27 Feb 2026
Brief summary (registry, in English)
SUMMIT RISE Study of Acute Ischemic Stroke Patients
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- First submitted
- 12 Feb 2026
- Start date
- Feb 2026
- Primary completion date
- May 2029
- Lead sponsor
- Route 92 Medical, Inc.
- Diseases
- Stroke
- NCT number
- NCT07436156
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 500
- From Feb 2026 to the primary completion date, May 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None
Who the study is looking for
- Acute ischemic stroke patient initially treated (first pass) with a Route 92 Medical Reperfusion System
- Informed consent completed and documented within 72 hours following thrombectomy procedure
- Endovascular treatment initiated (defined as time of groin puncture) within 8 hours from time last known well
- Age ≥ 18 years
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Route 92 Medical, Inc. Coordinator of this site? Confirm its status | West Jordan | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.